Study of hepato-renal syndrome in patients of cirrhotic ascites in an academic hospital

Muhammad Masrur Siam; Shahinul Alam; Fatema-Tuz-Zohora; M. Morshedul Alam Khan; M. Shah Alam; Nahid Akhter

doi:10.18203/2320-6012.ijrms20260225

Authors

Muhammad Masrur Siam Department of Medicine, Dhaka Medical College Hospital, Dhaka, Bangladesh
Shahinul Alam Department of Medicine, Dhaka Medical College Hospital, Dhaka, Bangladesh
Fatema-Tuz-Zohora Department of Surgery, Dhaka Medical College Hospital, Dhaka, Bangladesh
M. Morshedul Alam Khan Department of Medicine, Dhaka Medical College Hospital, Dhaka, Bangladesh
M. Shah Alam Department of Medicine and Gastroenterology, Ashulia Women and Children Hospital, Dhaka, Bangladesh
Nahid Akhter Department of Gynae and Obstetrics, Sher-E-Bangla Medical College, Barishal, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20260225

Keywords:

Hepatorenal syndrome, Cirrhosis of liver, Ascites, Renal dysfunction, Serum creatinine, eGFR

Abstract

Background: Acute renal impairment is common in patients with chronic liver disease, occurring in approximately one fifth of hospitalized patients with cirrhosis. Considering limited evidence of epidemiological information of this topic, the study was designed to identify the number of patients suffering from hepatorenal syndrome (HRS) among patients of cirrhotic ascites admitted in an academic hospital.

Methods: This hospital based cross-sectional type observational study was conducted at the department of medicine and gastroenterology. Total 100 subjects were interviewed. Data were collected by researcher with a structured questionnaire. After the interview the investigator recorded the collected information and later on transcribed into statistical software. Finally, data were analyzed by the SPSS 21.

Results: Total 100 subjects were studied and mean age was 46.31±10.75 years, ranging from 22 to 65 years. Majority of the participants were male (69%). The most common cause of cirrhosis of liver was chronic hepatitis B infection (45%), followed in second and third by NAFLD (25%) and chronic hepatitis C (18%). In according to the Child-Turcotte-Pugh class, about 51% were in CP class A, 36% were in class B and remaining 13% were in class C. Overall frequency of HRS was 17% and type 2 was predominant (7%-type 1 HRS vs 10%-type 2 HRS).

Conclusions: Less than one fifth of the patients developed HRS and it is associated with higher Child-Pugh class. However, further studies are needed to establish and use the findings.

Metrics

Metrics Loading ...

References

Crawford JM. Philadelphia P. Elsevier Saunders; 2005. Liver and biliary tract. 2005;877-938.

Heidelbaugh JJ, Sherbondy M. Cirrhosis and Chronic Liver Failure: Part II. Complications and Treatment. Am Fam Physician. 2006;74(5):767-76.

Low G, Alexander GJM, Lomas DJ. Hepatorenal Syndrome: Aetiology, Diagnosis, and Treatment. Gastroenterol Res Pract. 2015;2015:1-11. DOI: https://doi.org/10.1155/2015/207012

Bery A, Chhina RS, Sahota H, Puri S, Sandhu J. Clinical Profile of Hepatorenal Syndrome: Prospective Study. Am J Gastroenterol. 2015;5(1):37-40.

Devuni D. Hepatorenal Syndrome. Medscape. 2017.

Nguyen GC, Segev DL, Thuluvath PJ. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension. Clin Gastroenterol Hepatol. 2007;5(9):1092-9. DOI: https://doi.org/10.1016/j.cgh.2007.04.027

Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91-6. DOI: https://doi.org/10.1053/gast.2003.50016

Munoz SJ. The Hepatorenal Syndrome. Med Clin North Am. 2008;92(4):813-37. DOI: https://doi.org/10.1016/j.mcna.2008.03.007

Turban S, Thuluvath PJ, Atta M. Hepatorenal syndrome. World J Gastroenterol. 2007;13(30):4046-55. DOI: https://doi.org/10.3748/wjg.v13.i30.4046

Wadei HM, Mai ML, Nasimul A, Gonwa NA. Hepatorenal Syndrome: Pathophysiology and Management. CJASN Sept. 2006;1(5):1066-79. DOI: https://doi.org/10.2215/CJN.01340406

Runyon BA. Management of adult patients with ascites due to cirrhosis: An update. Hepatology. 2009;49(6):2087-107. DOI: https://doi.org/10.1002/hep.22853

Khan F, Samad M, Arif F. The Burden of Chronic Liver Disease Patients: Their Clinical and Laboratory Profiles at Jinnah Postgraduate Medical Centre, Karachi. J Med Res Heal Educ. 2018;2(1):1-7.

Qua CS, Goh KL. Liver cirrhosis in malaysia: Peculiar epidemiology in a multiracial asian country. J Gastroenterol Hepatol. 2011;26(8):1333-7. DOI: https://doi.org/10.1111/j.1440-1746.2011.06732.x

Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, et al. The epidemiology of cirrhosis in the United States a population-based study. J Clin Gastroenterol. 2015;49(8):690-6. DOI: https://doi.org/10.1097/MCG.0000000000000208

Das D, Mahtab M, Rahim M, Malakar D, Kabir A, Rahman S. Hepatitis B virus is leading cause of cirrhosis of liver in Bangladesh. Hepato Int. 2007;1(1):120.

Mukherjee PS, Vishnubhatla S, Amarapurkar DN. Etiology and mode of presentation of chronic liver diseases in India : A multi centric study. PLoS One. 2017;12(10):1-13. DOI: https://doi.org/10.1371/journal.pone.0187033

The World Bank. Rural population (% of total population). Data. Available at: https://data.worldbank.org/indicator/SP.RUR.TOTL.ZS?locations=BD. Accessed on 28 November 2025.

Alam S, Alam M, Alam SMNE, Chowdhury ZR, Kabir J. Prevalence and Predictor of Nonalcoholic Steatohepatitis (NASH) in Nonalcoholic Fatty Liver Disease (NAFLD). J Bangladesh Coll Physicians Surg. 2015;32(2):71. DOI: https://doi.org/10.3329/jbcps.v32i2.26034

Hossain SF, Islam QT, Siddiqui MR, Hossain A, Jahan N, Rahman YU, et al. A Study of Hypoalbuminaemia in Chronic Liver Disease and Its Correlation With. Bangladesh J Med. 2011;22:17-20. DOI: https://doi.org/10.3329/bjmed.v22i1.13595

Khan H, Iman NU. Hypoalbuminemia: A marker of esophageal varices in chronic liver disease due to hepatitis B and C. Rawal Med J. 2009;34(1):98-101.

Seetlani NK, Memon AR, Iftikhar F, Ali A, Fazel PA. Hepatorenal Syndrome In Patients With Cirrhosis Of Liver According To 2007 International Ascites Club Criteria. J Ayub Med Coll Abbottabad. 2016;28(3):578-81.

Siregar GA, Gurning M. Renal dysfunction in liver cirrhosis and its correlation with Child-Pugh score and MELD score. IOP Conf Ser Earth Environ Sci. 2018;125(1):. DOI: https://doi.org/10.1088/1755-1315/125/1/012214

Licata A, Maida M, Bonaccorso A, Macaluso FS, Cappello M, Craxì A, et al. Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study. World J Hepatol. 2013;5(12):685-91. DOI: https://doi.org/10.4254/wjh.v5.i12.685

Qureshi MO, Shafqat F, Dar FS, Salih M, Khokhar N. Renal Failure in Patients with End Stage Liver Disease and its Impact on Clinical Outcome. J Coll Physicians Surg Pakistan. 2014;24(9):628-31.